Browsing Tag
Neuroscientific Biopharmaceuticals Ltd
3 posts
Crohn’s disease market grows to $13.8bn—can NeuroScientific’s stem cell pivot capture real value?
Explore how NeuroScientific’s StemSmart therapy targets a $13.8B Crohn’s market with MSC innovation for hard-to-treat patient segments.
NeuroScientific Biopharmaceuticals stock watch: Can StemSmart turn NSB into a clinical-stage contender?
Is NeuroScientific Biopharmaceuticals the next stem cell breakout? Explore NSB’s clinical pivot, share surge, and StemSmart’s investor impact now.
Neuroscientific Biopharmaceuticals and ZIP Co lead ASX gainers as risk appetite returns to small-cap stocks
Find out how top ASX gainers like Neuroscientific and ZIP Co defied global volatility and what drove investor momentum on 16 April 2025.